CKD患者动态血压控制与ESKD及死亡风险的性别差异
该前瞻性研究纳入906例高血压CKD患者(男性553例),比较男女动态血压控制及ESKD和全因死亡风险。男性动态血压更高、达标率更低,且ESKD和死亡风险更高;校正动态血压达标后男性风险增加被削弱,动态血压达标与ESKD和死亡风险降低相关,性别与动态血压达标无交互作用。
要点
- 男性CKD患者动态血压更高,达标率低于女性。
- 男性ESKD和死亡风险更高,部分由动态血压差异解释。
- 动态血压达标与ESKD和死亡风险降低相关,男女一致。
核心结论
- 男性CKD患者动态血压更高,部分解释了其ESKD和死亡风险增加。
研究设计与样本
- 前瞻性评估906例高血压CKD患者(男性553例),在肾脏门诊规律随访。
主要发现
- 女性蛋白尿低于男性(0.30 g/24h IQR 0.10-1.00 vs 0.42 g/24h IQR 0.10-1.28,P=0.025)。
- 男性日间和夜间血压均高于女性,动态血压达标率女性39.1% vs 男性25.1%(P<0.001)。
- 中位随访10.7年,275例达ESKD(男性60.7%),245例死亡(男性62.4%)。
- 校正人口学和临床变量后,男性ESKD风险HR 1.34(95%CI 1.02-1.76),死亡风险HR 1.36(95%CI 1.02-1.83)。
- 校正动态血压达标后,男性ESKD风险HR 1.29(95%CI 0.98-1.70),死亡风险HR 1.31(95%CI 0.98-1.77);动态血压达标与ESKD风险HR 0.49(95%CI 0.34-0.70)和死亡风险HR 0.59(95%CI 0.43-0.80)相关。
关键数值与推荐
- 动态血压达标定义为日间<135/85 mmHg且夜间<120/70 mmHg。
临床怎么用
- 在CKD高血压患者中应重视动态血压监测,尤其男性,以识别血压控制不佳者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is unknown whether faster progression of chronic kidney disease (CKD) in men than in women relates to differences in ambulatory blood pressure (ABP) levels. METHODS: We prospectively evaluated 906 hypertensive CKD patients (553 men) regularly followed in renal clinics to compare men versus women in terms of ABP control [daytime <135/85 and nighttime blood pressure (BP) <120/70 mmHg] and risk of all-cause mortality and end-stage kidney disease (ESKD). RESULTS: Age, estimated glomerular filtration rate and use of renin-angiotensin system inhibitors were similar in men and women, while proteinuria was lower in women [0.30 g/24 h interquartile range (IQR) 0.10-1.00 versus 0.42 g/24 h, IQR 0.10-1.28, P = 0.025]. No sex-difference was detected in office BP levels; conversely, daytime and nighttime BP were higher in men (134 ± 17/78 ± 11 and 127 ± 19/70 ± 11 mmHg) than in women (131 ± 16/75 ± 11, P = 0.005/P < 0.001 and 123 ± 20/67 ± 12, P = 0.006/P < 0.001), with ABP goal achieved more frequently in women (39.1% versus 25.1%, P < 0.001). During a median follow-up of 10.7 years, 275 patients reached ESKD (60.7% men) and 245 died (62.4% men). Risks of ESKD and mortality (hazard ratio and 95% confidence interval), adjusted for demographic and clinical variables, were higher in men (1.34, 1.02-1.76 and 1.36, 1.02-1.83, respectively). Adjustment for office BP at goal did not modify this association. In contrast, adjustment for ABP at goal attenuated the increased risk in men for ESKD (1.29, 0.98-1.70) and death (1.31, 0.98-1.77). In the fully adjusted model, ABP at goal was associated with reduced risk of ESKD (0.49, 0.34-0.70) and death (0.59, 0.43-0.80). No interaction between sex and ABP at goal on the risk of ESKD and death was found, suggesting that ABP-driven risks are consistent in males and females. CONCLUSIONS: Our study highlights that higher ABP significantly contributes to higher risks of ESKD and mortality in men.
引用
- Minutolo R, Gabbai FB, Agarwal R, et al. Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care. Nephrol Dial Transplant. 2021. PMID: 33693796. doi:10.1093/ndt/gfab017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。